Literature DB >> 330063

Impaired antibody responses in alloxan diabetic mice.

W Ptak, M Hanczakowska, R Rózycka, D Rózycka.   

Abstract

Alloxan diabetic BALB/C mice with high hyperglycaemia levels (larger than or equal to 600 mg/100 ml) when immunized either with T-dependent (SRCB) or T-independent (TNP-LPS) antigens show a significant decrease in the number of specific PFC when compared with normo-glycaemic controls. Moderate diabetes (greater than 350 mg/100 ml) does not affect the immune response and in some experiments a slight increase of anti-SRBC plaques was seen. In transfer experiments primed spleen cells of either diabetic or normal doners gave much better responses when transferred to normal rather than diabetic X-irradiated recipients. In Mishell-Dutton (MD) cultures anti-SRBC response of CBA spleen cells was moderately reduced only when the blood glucose level of cell donors exceeded 500 mg/100 ml. Glucose added to MD cultures of normal spleen cells diminished significantly the number of SFC when in concentrations exceeding 600 mg/100 ml. The data indicate that in diabetic animals B-lymphocyte function may be affected but give no clear-cut answer to whether this is also true for T-helper cells. Disabled lymphocytes, whatever population they represent, may partially recover when transferred into normo-insulinic milieu. It may be inferred that under conditions tested neither hyperglycaemia nor excess of corticosteroid accounted significantly for the impaired humoral responses in diabetic animals. These experiments imply, however, that in hypoinsulinaemia the lack of saturation of insulin receptors on the lymphocyte, and possibly also macrophage, membranes renders these cells functionally inactive presumably due to accumulation of cyclic AMP in the cell membrane.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 330063      PMCID: PMC1541034     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Specific determination of blood glucose with o-toluidine.

Authors:  A HYVARINEN; E A NIKKILA
Journal:  Clin Chim Acta       Date:  1962-01       Impact factor: 3.786

2.  Alloxan and hypersensitivity.

Authors:  G E THOMPSON
Journal:  Nature       Date:  1961-05-27       Impact factor: 49.962

3.  Modulation of macrophage Fc receptor expression in vitro by insulin and cyclic nucleotides.

Authors:  J Rhodes
Journal:  Nature       Date:  1975-10-16       Impact factor: 49.962

4.  Insulin-induced augmentation of lymphocyte-mediated cytotoxicity.

Authors:  T B Strom; R A Bear; C B Carpenter
Journal:  Science       Date:  1975-03-28       Impact factor: 47.728

5.  Demonstration that monocytes rather than lymphocytes are the insulin-binding cells in preparations of humah peripheral blood mononuclear leukocytes: implications for studies of insulin-resistant states in man.

Authors:  R H Schwartz; A R Bianco; B S Handwerger; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

6.  Direct action of insulin on plasma membrane ATPase activity in human lymphocytes.

Authors:  J W Hadden; E M Hadden; E E Wilson; R A Good; R G Coffey
Journal:  Nat New Biol       Date:  1972-02-09

7.  Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen.

Authors:  M B Rittenberg; K L Pratt
Journal:  Proc Soc Exp Biol Med       Date:  1969-11

8.  Enhancing effect of insulin on the tuberculin reaction in the albino rat.

Authors:  G E Thompson
Journal:  Nature       Date:  1967-08-12       Impact factor: 49.962

9.  Immunogenicity of trinitrophenyl-hemocyanin: production of primary and secondary anti-hapten precipitins.

Authors:  M B Rittenberg; A A Amkraut
Journal:  J Immunol       Date:  1966-09       Impact factor: 5.422

10.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

Review 2.  Disordered cellular immunity in type I diabetes of man and the BB rat.

Authors:  J B Buse; R F Rowley; G S Eisenbarth
Journal:  Surv Immunol Res       Date:  1982

3.  Alleviation of IgE-mediated immune reactions in hypoinsulinaemic and hyperglycaemic mice.

Authors:  W Ptak; M Rewicka; J Strzyzewska; M Kollat
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

4.  Assessment of the diabetogenic drugs alloxan and streptozotocin as models for the study of immune defects in diabetic mice.

Authors:  G N Gaulton; J L Schwartz; D D Eardley
Journal:  Diabetologia       Date:  1985-10       Impact factor: 10.122

5.  Phagocytosis and chemotaxis of macrophages from normal and diabetic mice.

Authors:  E M Peterson; N A Ambe; I Valdes; E R Arquilla
Journal:  Acta Diabetol Lat       Date:  1981 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.